Clinical Trial Update: Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

View source ↗

Summary

A Hoffmann-La Roche–sponsored study on early rheumatoid arthritis in Algerian patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED